HYOSUN KIM: Open Payments
NPI 1477906709 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 44 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $356 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $209 |
| Arcutis Biotherapeutics, Inc. | 11 | $163 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| ABBVIE INC. | 4 | $110 |
| Organon LLC | 2 | $53 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| GENZYME CORPORATION | 1 | $35 |
| PFIZER INC. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $27 |
Products named: OPZELURA, Zoryve, SKYRIZI, COSENTYX, DUPIXENT, VTAMA, CIBINQO, Rhapsido.
Industry payments across NY — which companies pay providers there.
